Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Risk factors for hepatitis C virus infection in United States blood donors
2000
Melioidosis
2018 Standout
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines
2013 StandoutNobel
Heterosexual Transmission of Hepatitis C, Hepatitis B, and HIV-1 in a Sample of Inner-City Women
2000
Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
2009 Standout
Rising Incidence of Hepatocellular Carcinoma in the United States
1999 Standout
Tattoos and body piercings in the United States: A national data set
2006 Standout
Clinical Significance of Splenic Tuberculosis in Patients Infected with Human Immunodeficiency Virus
1997
Randomized trial comparing pegylated interferon α‐2b versus pegylated interferon α‐2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients†
2008
Understanding normal development of adolescent sexuality: A bumpy ride
2015 Standout
Major but differential decline in the incidence of Staphylococcus aureus bacteraemia in HIV‐infected individuals from 1995 to 2007: a nationwide cohort study*
2011
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Epidemiology of hepatitis C
1997 Standout
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Global Burden of Tuberculosis
1999 Standout
Hepatitis C Virus Infection in Chicago Women With or at Risk for HIV Infection
1998
Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease
1992
PROSPECTS FOR A HEPATITIS C VIRUS VACCINE
1999 StandoutNobel
High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C
1998 StandoutNobel
Tuberculosis in Patients Infected with Human Immunodeficiency Virus: Perspective on the Past Decade
1996
CD4 T Lymphocyte Proliferative Responses to Hepatitis C Virus (HCV) Antigens in Patients Coinfected with HCV and Human Immunodeficiency Virus Who Responded to Anti‐HCV Treatment
2002 StandoutNobel
Reciprocal Interactions Between Human Immunodeficiency Virus and Hepatitis C Virus Infections
1996
Perspectives for a vaccine against hepatitis C virus
1999 StandoutNobel
Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection
2010
Septicaemia in a population-based HIV clinical cohort in rural Uganda, 1996-2007: incidence, aetiology, antimicrobial drug resistance and impact of antiretroviral therapy
2010
Bloodstream Infections
2008
HCV epidemiology in high-risk groups and the risk of reinfection
2016
Epilepsy and quality of life in adults: A review of instruments
2005
Control of Nosocomial Acquisition of Vancomycin-Resistant Enterococcus Through Active Surveillance of Hemodialysis Patients
2004
The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia
1995
Commercial Tattooing as a Potentially Important Source of Hepatitis C Infection
2001
Diagnosis and Treatment of Tuberculous Pleural Effusion in 2006
2007 Standout
Detection of hepatitis C virus-specific antigens in semen from non-A, non-B hepatitis patients
1992
Hospital safety climate and its relationship with safe work practices and workplace exposure incidents
2000 Standout
Strategies and Prospects for Vaccination Against the Hepatitis C Viruses
2000 StandoutNobel
Hepatitis B and Hepatitis C in Emergency Department Patients
1992
Infrequent Vertical Transmission of Hepatitis C Virus
1993
The Growing Burden of Tuberculosis
2003 Standout
Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations
2015 Standout
Relationship of the Manifestations of Tuberculosis to CD4 Cell Counts in Patients with Human Immunodeficiency Virus Infection
1993
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates
2000 StandoutNobel
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Hepatitis C virus infection among a cohort of Victorian injecting drug users
1993
Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus
1994 StandoutNobel
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
2006 Standout
Bloodstream infections in HIV-infected patients
2016
Sexual Behavior and Selected Health Measures: Men and Women 15-44 Years of Age, United States, 2002
2005 Standout
The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study
1992
Cationic microparticles are a potent delivery system for a HCV DNA vaccine
2004 StandoutNobel
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Antibody response to core, envelope and nonstructural hepatitis C virus antigens: Comparison of immunocompetent and immunosuppressed patients
1993 StandoutNobel
Oral sex and the transmission of viral STIs
1998
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
2020 Standout
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
2016 StandoutNobel
Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial.
1997
Works of Tor J being referenced
Changes in bloodstream infections in HIV positive patients in a university hospital in Spain (1995–1997)
2002
Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy.
2005
Risk Stratification for Dissemination of Tuberculosis in HIV-Infected Patients
1992
[Neurophysiological and therapeutic evaluation of stiripentol in epilepsy. Preliminary results].
1988
[Abdominal tuberculosis in patients with acquired immunodeficiency syndrome].
1991
Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV.
1990